Sign in
Not yet recruitingPhase 3

Glutamine Early Start in Children With SCD Younger Than Five

Key facts

Who runs it
Ain Shams University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
Phase
Phase 3
People taking part
70 people, planned
Starts
1 Dec 2026
Expected to end
1 Mar 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Glutamine
  • Standard of Care (SOC)
Record updated
17 November 2026

Who can take part

Age
1 year to 5 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (4)Hide the full registry criteria

Who can take part

  • Age from 1-5 years
  • children diagnosed with SCD based on clinical picture, CBC, reticulocyte count, markers of hemolysis and hemoglobin analysis by HPLC

Who cannot take part

  • Patients with clinically significant renal or liver disease
  • Patients with any clinical evidence of infection

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Sickle cell disease

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

A study to assess the efficacy and safety of Glutamine in preventing Vaso Occlusive Crisis in pediatric population less than five years old

The 2 groups in the trial

  • Patients receiving standard of careExisting treatment, for comparison

    Treatment: Standard of Care (SOC)

  • Patients receiving GlutamineTreatment being tested

    Treatment: Glutamine and Standard of Care (SOC)

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Safety and Efficacy of Glutamine in Preventing Vaso-occlusive Crisis Among Children With Sickle Cell Disease Younger Than Five
Criteria questions
Built from NCT07940569, who can take part
Record updated
17 November 2026